Microbial Glucosamine Production: Current Strategies, Process Bottlenecks, and Future Perspectives

Glucosamine and its derivatives have been extensively used in the nutraceutical, cosmetic, food and pharmaceutical industries. Commercial glucosamine production traditionally relies on the acid or enzymatic hydrolysis of crustacean shells, particularly those of shrimp and crabs. However, these processes are often associated with high production costs, environmental concerns, extensive chemical usage, and the generation of hazardous waste. In recent years, microbial production of glucosamine has emerged as a sustainable and environmentally friendly alternative, offering advantages such as milder processing conditions, reduced chemical inputs, and improved process scalability. Microbial approaches include direct glucosamine biosynthesis by native microorganisms, bioconversion of chitin-rich substrates by chitinolytic microbes, and metabolic engineering of recombinant strains for enhanced production. This review explores microbial approaches for glucosamine production, including direct biosynthesis, chitin bioconversion, and recombinant microbial systems. Key challenges related to substrate utilization, process scalability, strain stability, and product recovery are critically evaluated, along with emerging solutions involving metabolic engineering and process optimization. Additionally, strategies to overcome such challenges such as CRISPR-based gene editing, optimization of culture and fermentation conditions etc. have been discussed. This review emphasizes the fact that while microbial production of glucosamine offers clear environmental and economic advantages, their large-scale feasibility depends on addressing these challenges through integrated approaches.